GLNBX
Price
$22.20
Change
+$0.01 (+0.05%)
Updated
Sep 16 closing price
Net Assets
72.87M
RSLBX
Price
$63.88
Change
+$0.14 (+0.22%)
Updated
Sep 16 closing price
Net Assets
81.91B
Interact to see
Advertisement

GLNBX vs RSLBX

Header iconGLNBX vs RSLBX Comparison
Open Charts GLNBX vs RSLBXBanner chart's image
MFS Global New Discovery B
Price$22.20
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets72.87M
American Funds SMALLCAP World R2
Price$63.88
Change+$0.14 (+0.22%)
VolumeN/A
Net Assets81.91B
GLNBX vs RSLBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GLNBX vs. RSLBX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLNBX is a Hold and RSLBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 81.9B vs. GLNBX (72.9M). RSLBX pays higher dividends than GLNBX: RSLBX (0.06) vs GLNBX (0.00). GLNBX was incepted earlier than RSLBX: GLNBX (14 years) vs RSLBX (23 years). GLNBX (2.56) is less costly to investors than RSLBX (1.75). GLNBX is a more actively managed with annual turnover of: 37.00 vs. RSLBX (32.00). RSLBX has a lower initial minimum investment than GLNBX: RSLBX (250) vs GLNBX (1000). RSLBX annual gain was more profitable for investors over the last year : 9.60 vs. GLNBX (7.30). GLNBX (11.28) and RSLBX (10.89) have equivalent 5 years return.
GLNBXRSLBXGLNBX / RSLBX
Total Expense Ratio2.101.75120%
Annual Report Gross Expense Ratio2.561.75146%
Fund Existence14 years23 years-
Gain YTD11.89512.07798%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets72.9M81.9B0%
Annual Yield % from dividends0.000.06-
Returns for 1 year7.309.6076%
Returns for 3 years39.2734.86113%
Returns for 5 years11.2810.89104%
Returns for 10 years55.3545.06123%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIAHX14.96N/A
N/A
Hartford Healthcare HLS IA
CEMFX15.51N/A
N/A
Cullen Emerging Markets High Div I
MDOAX11.66N/A
N/A
Morgan Stanley Developing Opportunity A
GCLLX17.85N/A
N/A
Goldman Sachs Enhanced U.S. Equity C
BHSRX57.01N/A
N/A
BlackRock Health Sciences Opps R